Unravelling Checkpoint Inhibitor Associated Autoimmune Diabetes: From Bench to Bedside

by Linda Wu, Linda Wu, Linda Wu, Linda Wu, Venessa H. M. Tsang, Venessa H. M. Tsang, Sarah C. Sasson, Sarah C. Sasson, Sarah C. Sasson, Alexander M. Menzies, Alexander M. Menzies, Alexander M. Menzies, Matteo S. Carlino, Matteo S. Carlino, Matteo S. Carlino, David A. Brown, David A. Brown, David A. Brown, David A. Brown, Roderick Clifton-Bligh, Roderick Clifton-Bligh, Jenny E. Gunton, Jenny E. Gunton, Jenny E. Gunton
Published 2021

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition

by Jenny H. Lee, Elena Shklovskaya, Su Yin Lim, Matteo S. Carlino, Alexander M. Menzies, Ashleigh Stewart, Bernadette Pedersen, Malama Irvine, Sara Alavi, Jean Y. H. Yang, Dario Strbenac, Robyn P. M. Saw, John F. Thompson, James S. Wilmott, Richard A. Scolyer, Georgina V. Long, Richard F. Kefford, Helen Rizos
Published 2020

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition

by Dirk Schadendorf, Lisa Zimmer, Serigne Lo, Caroline Robert, John Haanen, Ines Pires da Silva, Paolo Antonio Ascierto, Reinhard Dummer, Michael Manos, Joanna Mangana, Richard D Carvajal, Georgina V Long, Alon Vaisman, Christian Posch, Paola Queirolo, Axel Hauschild, Christian U Blank, Maria Grazia Vitale, Carlo Alberto Tondini, Arielle Elkrief, Karijn P M Suijkerbuijk, Mario Mandala, Alexander M Menzies, Aljosja Rogiers, Chiara Tentori, Joseph M Grimes, Megan H Trager, Sharon Nahm, Peter Bowling, Neha Papneja, April A N Rose, Jessica S W Borgers, Severine Roy, Thiago Pimentel Muniz, Tim Cooksley, Jeremy Lupu, Samuel D Saibil, Matteo S Carlino, Michael Erdmann, Laura Pala, Wilson H Miller Jr, Osama E Rahma, Paul C Lorigan
Published 2021